Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients

NCT03821038 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Stopped PK issue detected after bolus IV route administration

Conditions

Sepsis, Severe

Interventions

BIOLOGICAL: CYT107
DRUG: Placebos

Sponsor

Revimmune

Collaborators

[object Object]
[object Object]
[object Object]